You have 9 free searches left this month | for more free features.

lcl161

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (PDR001, CJM112, LCL161)

Completed
  • Multiple Myeloma
  • Phoenix, Arizona
  • +7 more
Feb 7, 2022

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Tumors Trial in Nagoya-city, Kobe-city (LCL161, Paclitaxel)

Completed
  • Neoplasms
  • Nagoya-city, Aichi, Japan
  • +1 more
Dec 16, 2020

Solid Tumors Trial in Worldwide (LCL161, Paclitaxel)

Completed
  • Solid Tumors
  • Boston, Massachusetts
  • +6 more
Dec 16, 2020

Breast Cancer Trial in Worldwide (LCL161, paclitaxel)

Completed
  • Breast Cancer
  • Fayetteville, Arkansas
  • +49 more
Aug 30, 2016

Metastatic Pancreatic Cancer Trial in incl Tyler, TX and Dallas, TX (LCL161, Gemcitabine, nab-Paclitaxel)

Unknown status
  • Metastatic Pancreatic Cancer
  • LCL161
  • +2 more
  • incl Tyler, TX and Dallas, TX, Texas
    2 Sites
Nov 7, 2015

Advanced Solid Tumors Trial in Chapel Hill, Philadelphia, Nashville (LCL161)

Completed
  • Advanced Solid Tumors
  • LCL161
  • Chapel Hill, North Carolina
  • +2 more
Aug 2, 2012